Clinical Trial Update: Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating two doses of duloxetine and amitriptyline for efficacy in refractory chronic cough and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• Cymbalta (duloxetine)
• Elavil (amitriptyline)

Snippet

Sponsor: Mayo Clinic | Conditions: Refractory Chronic Cough | Phase 2 | Status: RECRUITING